FindTrial
Sign In

A study on salivary samples and nasopharyngeal samples in diagnosis of COVID-19 Disease Patients

A prospective study to compare the reliability of salivary samples paired nasopharyngeal in COVID-19 Infection -An Indian study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025243
Enrollment
40
Registered
2020-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Medanta Institute of Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults above the age of 18 years, who give consent to collect saliva samples independently according to the CDC guidelines The IPD/OPD adults who are confirmed positive and negative for COVID-19 infection, by rRT-PCR of NP swabs done at NABL accredited laboratory.

Exclusion criteria

Exclusion criteria: Patients who are on drugs affecting saliva production like anticholinergics. Patients who have xerostomia or any active oral disease or injury. Patients who are mechanically ventilated or critically ill.

Design outcomes

Primary

MeasureTime frame
To compare the sensitivity and specificity of paired salivary samples and nasopharyngeal samples in diagnosis of COVID-19 infectionTimepoint: Day 0,7 and 14—

Secondary

MeasureTime frame
To compare result of both testsTimepoint: Day 0, 7 and 14—

Countries

India

Contacts

Public ContactKuldeep K Chauhan
vikas.deswal@medanta.org9992837902

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026